Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 367,024 | 98,959 | 71,059 | 11,446 | 17,485 |
| Depreciation Amortization | 1,265 | 907 | 771 | 414 | 1,519 |
| Income taxes - deferred | -245,852 | N/A | N/A | N/A | N/A |
| Accounts receivable | -10,148 | -4,310 | 1,708 | 68 | -11,065 |
| Accounts payable and accrued liabilities | 3,852 | 507 | 3,951 | 615 | -3,803 |
| Other Working Capital | -19,512 | -16,173 | -8,805 | -16,077 | 153 |
| Other Operating Activity | -20,974 | -26,215 | -39,040 | 2,641 | 27,182 |
| Operating Cash Flow | $75,655 | $53,675 | $29,644 | $-893 | $31,471 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -92,365 | -66,991 | -33,828 | -10,552 | 4,428 |
| PPE Investments | N/A | -12 | N/A | N/A | 62 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -360 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -360 |
| Investing Cash Flow | $-92,365 | $-67,003 | $-33,828 | $-10,552 | $4,130 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7,500 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 8,101 | 5,173 | 902 | 484 | 1,964 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -13,605 |
| Financing Cash Flow | $601 | $5,173 | $902 | $484 | $-11,641 |
| Beginning Cash Position | 56,746 | 56,746 | 56,746 | 56,746 | 32,786 |
| End Cash Position | 40,637 | 48,591 | 53,464 | 45,785 | 56,746 |
| Net Cash Flow | $-16,109 | $-8,155 | $-3,282 | $-10,961 | $23,960 |
| Free Cash Flow | |||||
| Operating Cash Flow | 75,655 | 53,675 | 29,644 | -893 | 31,471 |
| Capital Expenditure | N/A | -12 | N/A | N/A | -36 |
| Free Cash Flow | 75,655 | 53,663 | 29,644 | -893 | 31,435 |